Clariant’s shareholders approve all agenda items


Clariant IMG 25th AGM Hariolf Kottmann
  • Extraordinary distribution of CHF 3.00 per share, subject to the closing of the Masterbatches transaction, confirmed
  • Withholding of regular distribution and carrying forward to available earnings confirmed
  • Nader I. Alwehibi and Thilo Mannhardt newly elected as members of the Board of Directors

Muttenz, June 29, 2020 – At today’s Annual General Meeting in Basel, the shareholders of Clariant Ltd, a focused, sustainable and innovative specialty chemical company, approved all agenda items and resolutions proposed by the Board of Directors. Due to the ongoing situation with regard to the spread of the coronavirus, shareholders could not attend this year’s Annual General Meeting in person and could exercise their rights exclusively via the independent proxy. Overall, 222 864 693 shares or around 67.14 % of the share capital of Clariant were represented.

Hariolf Kottmann, Executive Chairman ad interim, said: “The results we achieved in the year 2019 in a challenging economic and political environment prove the resilience of our portfolio. They also confirm the success of our long-term strategy with which we want to move further into the leading group of the specialty chemicals industry. Clariant's development over the last 25 years is a story of constant change, and even in an ever-changing environment Clariant will also have a good future.”

At the Annual General Meeting, the Integrated Report as well as the Financial Statements and Consolidated Financial Statements of Clariant for the 2019 fiscal year were approved with 99.96 % of the votes. The 2019 Compensation Report was also approved on an advisory basis with 87.93 % of the votes. The members of the Board of Directors and the Executive Committee were discharged with 95.04 % of the votes. In addition, the Annual General Meeting approved the withholding of a regular distribution and the appropriation of the accumulated profit for 2019 to voluntary retained earnings with 99.56 % of the votes. The proposal for an extraordinary distribution of CHF 3.00 per share, subject to the closing of the Masterbatches transaction, was approved with 97.18 % of the votes.

Nominated by the Board of Directors, Nader I. Alwehibi (*1980), a Saudi Arabian citizen, and Thilo Mannhardt (*1954), a German citizen, were elected as board members by a large majority of the votes. Khaled Homza A. Nahas and Carlo G. Soave resigned from the Board of Directors. The newly elected members of the Board of Directors were appointed until the Annual General Meeting 2021.

The ten other members of the Board of Directors were also reelected by a large majority until the Annual General Meeting 2021, as was the Chairman of the Board of Directors, Hariolf Kottmann. Further, Dr. Balthasar Settelen, attorney, was reelected as independent proxy until the Annual General Meeting 2021 and PricewaterhouseCoopers AG was confirmed as the statutory auditor for 2020.

Eveline Saupper, Independent Lead Director, said: "I want to thank the shareholders for the trust they place in the Board of Directors. This strengthens me to fulfill my duty as Independent Lead Director until a new CEO has been appointed and Clariant again has two individuals for the positions of CEO and Chairman."

The proposal for total compensation of the Board of Directors for the term from the 2020 to the 2021 Annual General Meeting was approved with 87.79 % of the votes, as was the total compensation of the Executive Committee for the 2021 fiscal year, with 89.29 % of the votes.

The speech (German only) of Hariolf Kottmann, Chairman of the Board of Directors ad interim, along with pictures and the recordings of the live broadcast will shortly be available on http://www.clariant.com/Investors/Events/Annual-General-Meetings

免責条項:
この情報は、当社の現在の知識に基づくものであり、製品および考えられる用途の概要として提供されています。クラリアントは、明示または黙示を問わず、情報の正確性、妥当性、充足性、欠陥が無いことを保証しません。この情報の使用に関して、当社は一切の責任を負いかねます。当該製品の使用者は全て、それぞれ特定の用途に関して、クラリアントの製品の適合性を各自で判断する責任があります。<br />
<br />
*この情報に含まれるいかなる内容も、書面による別段の同意がある場合を除き、それを支配する「クラリアント販売取引約款」のいかなる条項の適用除外にはなりません。既存の知的/産業財産権は遵守しなければなりません。当社の製品、また適用される国内および国際的な規制や法律において起こり得る変更のため、製品の状況が変更になる可能性があります。製品安全性データシートは安全上の注意事項を示しており、クラリアント製品の取扱いと保存に際して準拠しなければなりません。データシートは希望に応じて入手可能であり、適用法に従って提供されます。これらの製品のいずれかを取り扱う場合は、該当する製品の安全性データシートの情報を事前に入手し、確認してください。詳しい情報については、クラリアントまでお問い合わせください。<br />
<br />
*米国およびカナダ国内に所在する顧客への販売については、下記事項が追加で適用されます。明示または黙示を問わず、商品性、適切性、特定の目的に対する適合性あるいは、いかなる製品またはサービスも保証しません。<br />
<br />
クラリアントの商標は、多くの国で登録されています。<br />
® 2019 Clariant International Ltd 

まもなくクラリアントのドメインから移動します。

お客様が有効化したリンクにより、約10秒後にクラリアントのウェブサイト外に移動します。この操作を中止したい場合は、「Cancel(キャンセル)」をクリックしてください。

クラリアントへのリクエスト

お客様のリクエストを処理するため、ご連絡先情報を入力してください。関心をお寄せいただきありがとうございました。

Clariant Info
Clariant Info
Online Communications Team